|
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain
RECRUITINGPhase 1Sponsored by R3 Stem Cell
Actively Recruiting
PhasePhase 1
SponsorR3 Stem Cell
Started2024-03-25
Est. completion2027-03-31
Eligibility
Age20 Years+
Healthy vol.Accepted
Locations4 sites
View on ClinicalTrials.gov →
NCT06361485
Summary
This is a Pilot Study that is an open label, prospective, non-controlled study in which the safety and feasibility of Wharton's Jelly (WJ) allograft will be evaluated in 100 participants suffering with low back pain.
Eligibility
Age: 20 Years+Healthy volunteers accepted
Inclusion Criteria: • Patient must * Be over age 20. * Suffering from chronic lumbar pain * Body Mass Index (BMI) \<50 Kilograms/m2. * Pain score of 4 or more on the Numeric Pain Rating Scale (NPRS). * Female participants must be abstinent, surgically sterilized or postmenopausal. * Premenopausal females must be on contraceptive measures and do not anticipate pregnancy during the duration of the study. * Be willing and capable of giving written informed consent to participate in English. * Be willing and capable of complying with study-related requirements, procedures and visits. Exclusion Criteria: • Patient must not * Have taken any pain medication including nonsteroidal anti-inflammatory drugs (NSAIDs) within 2 weeks prior to study injection date. * Use anticoagulants have a substance abuse history, and fail to agree not to take any lumbar symptom modifying drugs during the course of the study without discussing and reporting the use to the site Clinical investigator and study team. * Known allergy to penicillin, sulfa or amphotericin medications. * Have had any lumbar injections (at all) of any drug in lumbar spine in the past 6 months. * Have had surgery on the lumbar spine within the past 6 months. * Had a traumatic injury to the lumbar spine with the past 3 months. * Planned elective surgery during the course of the study. * A history of organ or hematologic transplantation, rheumatoid arthritis, or other autoimmune disorders. * Be on immunosuppressive medications. * Have a diagnosis of carcinoma with the past 5 years. * Have a lumbar infection or have used antibiotics for lumbar infection within the past 3 months. * Have participated in any other clinical study or treatment (not just for the lumbar spine, but for any reason) with any investigational product within the past 30 days prior to inclusion of study. * Female participants who are breast feeding or are pregnant or desire to become pregnant during the course of the study. * Contraindications to radiographic or MRI imaging. * Serious neurological, psychological or psychiatric disorders. * Injury or disability claims under current litigation or pending or approved workers compensation claims.
Conditions2
ArthritisLow Back Pain
Locations4 sites
Arizona
1 siteR3 Anti Aging Scottsdale
Scottsdale, Arizona, 85262
California
1 siteR3 Anti Aging Beverly Hills
Beverly Hills, California, 90210
New York
1 siteScheer Medical Wellness
New York, New York, 10036
Texas
1 siteBrowse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 1
SponsorR3 Stem Cell
Started2024-03-25
Est. completion2027-03-31
Eligibility
Age20 Years+
Healthy vol.Accepted
Locations4 sites
View on ClinicalTrials.gov →
NCT06361485